AAAndrew Sime Awori

Andrew Sime Awori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew Sime Awori has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lassa fever case management capacity in ECOWAS: A multi-country epidemiological and operational assessment, 2020–2024

    by Awori Andrew Sime, Lionel Solété Sogbossi, Virgil Kuassi Lokossou, Aishat Usman, Félix Agbla

    Introduction Lassa fever is a zoonotic viral hemorrhagic disease endemic to West Africa, with a significant burden in ECOWAS countries. Transmitted primarily through Mastomys natalensis rodent excreta and human-to-human contact, it has high case fatality rates (CFR) and causes nosocomial outbreaks due to delayed diagnosis and weak infection prevention and control (IPC). Despite frequent outbreaks, case management remains fragmented, with disparities in diagnostics, treatment access, and IPC implementation. This study assessed Lassa fever case management capacity in ECOWAS countries from 2020–2024 to identify gaps in clinical care, laboratory infrastructure, and healthcare worker (HCW) preparedness, informing policy recommendations for improved epidemic response. Methods A cross-sectional, multi-country assessment was conducted from 2020–2024 using data from national surveillance systems, treatment centers, and public health institutions. A standardized questionnaire targeted: Study population: National health agencies, hospitals, and Lassa treatment centers Eligibility: Facilities managing Lassa cases or involved in surveillance Data collection: Surveys, interviews, and retrospective data review Outcomes: Case counts, fatalities, CFR, lab capacity (RT-PCR and turnaround), IPC measures, treatment protocols, HCW training, and cross-border coordination Analysis: Descriptive statistics to assess regional disparities. Results Between 2020–2024, 42,301 suspected Lassa cases were reported in ECOWAS, with 5,716 confirmed and 1,130 deaths (CFR: 20%). Nigeria had the most confirmed cases (5,345) and an 18% CFR; Sierra Leone had a CFR of 67%. Lab turnaround varied: Nigeria (66 hrs), Ghana (108 hrs), Liberia (48 hrs). Treatment guidelines and Ribavirin access were inconsistent. HCW training was lacking in several countries. Poor cross-border data-sharing further weakened preparedness. Conclusion Critical gaps remain in diagnostics, treatment, HCW training, and regional coordination. Urgent priorities include standardizing protocols, strengthening labs, training HCWs, and enhancing data-sharing. A unified, regionally coordinated response is vital for improved Lassa fever control.

  • Open Access

    Enhancing digital disease surveillance in the ECOWAS Region: Progress, challenges, and way forward

    by Virgil Kuassi Lokossou, Victor Adeola Fatimehin, Andrew Awori Sime, Lionel Solété Sogbossi, Aishat Usman, Tome Ca, Alpha Savane, Damola Olajide, Issiaka Sombie, Felix Agbla, et al.

    Introduction: Digitalizing disease surveillance improves case reporting and enables timely outbreak detection and response, enhancing health outcomes. However, adoption in Africa remains limited. This study assessed the integration of digital platforms into surveillance systems and explored health leaders’ perspectives across the ECOWAS region. Methods: A cross-sectional study with a mixed-methods sequential exploratory design was conducted. Data collection involved a desk review (2015–2023 literature, reports, grey literature), an email-based survey, and expert consultations during a 3-day regional workshop. Survey participants were heads of surveillance, data policy, and health IT (SDH) units representing human and animal health sectors in all 15 ECOWAS Member States. Legal and technical experts also contributed. Results: Digital platform adoption was universal at the national level (100%) but only 50% at the community and lowest administrative levels, with variability across and within countries and sectors. Human health had full adoption (100%), while animal health adoption was lower (43%). DHIS2 was the most widely used platform. Human health reported higher single-platform use (73%, mostly DHIS2), compared to animal health (33%) using KoboToolbox (20%), DHIS2 (6%), and SISMAZ (7%). Key challenges included lack of interoperability and fragmented implementation. Survey and expert consensus supported establishing a harmonized data collection system and a regionally coordinated digital emergency response network, such as a regional Emergency Operations Center (EOC). Conclusion: Despite moderate adoption, digital surveillance systems in ECOWAS remain fragmented, particularly at lower administrative levels and in the animal health sector. To improve outbreak detection and response, ECOWAS must prioritize interoperable, integrated digital systems and establish a regional data exchange framework. Leveraging emerging technologies and standardizing platforms will be essential for building a resilient and responsive surveillance architecture.


  • Open Access

    Assessing mpox epidemic readiness status in ECOWAS region: strengths, gaps, and recommendations for an improved response

    by Virgil Kuassi Lokossou, Andrew Sime Awori, Victor Fatimehin, Aishat Bukola Usman, Lionel Sogbossi, Felix Agbla, Melchior Athanase Aïssi, Issiaka Sombie

    Mpox (formerly known as monkeypox) has re-emerged as a significant public health threat in West Africa, creating new challenges for regional and national health systems. Drawing from past outbreaks, the West African Health Organization (WAHO) has been proactive in enhancing public health preparedness, aligned with WHO recommendations. This study aims to assess the readiness of the ECOWAS region to manage the ongoing mpox outbreak, focusing on critical areas of national epidemic preparedness and response. A survey using the WHO mpox-epidemic readiness checklist tool was conducted in 14 ECOWAS Member States from August 25 to September 15, 2024. Key stakeholders, including Directors of Public Health and Heads of National Public Health Institutes, participated in the assessment. Mpox preparedness meetings and training reports from WAHO were also reviewed to evaluate the region’s efforts. A thematic analysis identified key themes, strengths, challenges, and gaps in mpox readiness. The findings revealed considerable variations in readiness across ECOWAS countries. Strengths include established coordination structures, operational surveillance systems, and developed risk communication plans. However, there are major gaps in laboratory capacity, case management, and logistics. Countries such as Liberia and Guinea-Bissau lack sufficient healthcare workers and ICU facilities for managing severe mpox cases. In Senegal and The Gambia, inadequate adaptation and translation of Information, Education, and Communication (IEC) materials hamper public awareness. Logistic challenges, particularly the absence of emergency supply mechanisms and cold chain capacity, also hinder effective responses. Despite progress in mpox preparedness, ECOWAS countries must address significant gaps in laboratory capacity, healthcare infrastructure, and logistics through enhanced coordination and investments.


  • Open Access

    Lassa fever case management capacity in ECOWAS Region: Progress, gaps, and policy recommendations

    by Kuassi Virgil Lokossou, Andrew Sime Awori, Aishat Usman, Audu Onyemocho, Winifred Sandra Ukponu, Lionel Sogbossi, Kehinde Ogunyemi, Issiaka Sombie, Melchior Athanase Aïssi

    Introduction: Lassa fever remains a significant public health concern in the ECOWAS region. Prompt diagnosis and effective case management are critical for controlling outbreaks and reducing associated mortality and severe complications. This study assessed the case management capacity for Lassa fever across ECOWAS member states, focusing on early detection, diagnostics, treatment infrastructure, and infection prevention and control (IPC) measures. Methods: A cross-sectional, mixed-methods study was conducted using structured questionnaires, key informant interviews, and document reviews in 10 ECOWAS member states. The evaluation encompassed diagnostic capacities, treatment availability, IPC measures, and workforce readiness. Thematic and comparative analyses were employed to synthesize the findings. Results: Considerable differences were observed across participating Member States. Nigeria, Guinea, and Liberia demonstrated relative strengths in diagnostics and treatment infrastructure. In contrast, countries such as Gambia, Ghana, and Côte d’Ivoire exhibited serious shortcomings, revealing significant deficiencies in healthcare worker training and access to antiviral therapies. The implementation of standardised case management protocols was inconsistent. Additionally, data sharing challenges and inadequate coordination across borders were highlighted as significant issues. Conclusion: While progress has been made, substantial gaps remain in Lassa fever case management across ECOWAS. Strategic investments in health systems strengthening, legal frameworks development for data sharing, and capacity building are critical to improving regional preparedness and reducing the risk of future outbreaks.